Real World Evidence

BBCR Company News

Why choose BBCR for your product development needs?

July 12th, 2022 | Real World Evidence

BBCR can help streamline product development and help to successfully navigate your clinical and regulatory journey. BBCR focuses on: Acceleration Cost-effectiveness Risk reduction Data collection and analysis support  

BBCR can help medical device companies with clinical data strategy from conception to market, from preparing due-diligence ready datasets for funders to post-marketing safety surveillance for regulatory authorities.

July 6th, 2022 | Real World Evidence

Medical devices have their own special complications as it relates to clinical trials. We work closely with each client to bring device innovation to market faster and more affordably. Working with the BBCR team will help that streamlines clinical trials and help you get through the process faster and more efficiently. BBCR consulting offers the […]

BBCR has extensive experience in early development Phase 1 and 2, from pre-clinical to pre-IND. BBCR’s early drug development experience includes the development of clinical strategy and plan, including target product profiles and clinical protocols.

June 30th, 2022 | Real World Evidence

Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process and strategy. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.  

BBCR’s team of professionals can help with your Pre-ind Integrated Development Plan

June 15th, 2022 | Real World Evidence

A strategy that clearly marks the path to success creates opportunity to reduce risk. BBCR works with clients to achieve a successful pre-IND meeting by: Reviewing scientific data Setting regulatory strategy Setting integrated plan Creating messages and outlines Developing realistic Q&As Providing constructive critique

In an ever-changing regulatory environment, the BBCR team of specialists in Orphan and Personalized Medicine can help clients identify areas of need or economic interest – and helps secure opportunities for treatments for rare diseases and precision medicine.

June 6th, 2022 | Real World Evidence

BBCR helps orphan drug developers find direction in clinical trials involving biologics, biosimilars, small molecules, medical devices, and repurposing. BBCR consultants have the experience to guide you through the development process with a clinical plan and a regulatory strategy. Our team will empower you with medical insight, effective regulatory expertise, strategy, and streamlined early clinical […]

BBCR Consulting offers world-class regulatory, clinical research, and biomarker consulting services that provide high-value, and support our clients’ operational and functional needs. Our SCIO process is designed to maximize time efficiencies, risk mitigation, and cost savings.

May 31st, 2022 | Real World Evidence

Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. BBCR Consulting has created a process called SCIO (Strategic Clinical Innovation Organization), designed to change the path from pre-clinical trial to market by creating a regulatory […]

Streamlining clinical development with clinical and regulatory expertise is the cornerstone of our business. BBCR’s mission is to streamline your clinical development while reducing costs and improving safety.

May 24th, 2022 | Real World Evidence

BBCR Consulting offers world-class regulatory, clinical research, and biomarker consulting services that provide high-value, and support our clients’ operational and functional needs. Our process is designed to maximize time efficiencies, risk mitigation, and cost savings. Innovating the process of drug development with clinical and regulatory expertise is the central value of our business. BBCR’s mission […]

BBCR embraces innovative strategy consulting for highly effective clinical development plan and regulatory strategy. Reach out today to learn more about how we can help advance your project.

May 18th, 2022 | Real World Evidence

Our industry needs innovative strategies, and reduced-risk clinical trials. BBCR clinical development services and drug development consulting integrates real world evidence into clinical development plans and regulatory strategies. We ensure that focus goes towards cost containment and value-based developments that allow sponsors to move more treatments to market faster. BBCR’s team expertise in rare diseases […]

Boston Biotech Clinical Research specializes in rare disease, working with biotech, pharmaceutical, investors and device companies to help streamline the clinical trial process.

May 11th, 2022 | Real World Evidence

Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. BBCR Consulting offers world-class regulatory, clinical research, and biomarker consulting services that provide high-value, and support our clients’ operational and functional needs. Our process is designed […]

BBCR’s team of experts help clients match treatments to rare genetic conditions and unsolved diseases, then work cohesively with a product developer on the best plan to market.

May 4th, 2022 | Real World Evidence

Did you know that about a third of orphan approvals by the FDA since the program began have been mostly for repurposed mass-market drugs? Drug repurposing acts to lower the need for early stage clinical trials and can help identify new uses for existing drugs. We invite you to learn more about how BBCR can […]

Pin It on Pinterest